Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.

Pharyngo-laryngeal involvement in systemic amyloidosis with cardiac involvement: a prospective observational study.

Bartier S, Bodez D, Kharoubi M, Canouï-Poitrine F, Chatelin V, Henrion C, Coste A, Damy T, Béquignon E.

Amyloid. 2019 Jul 31:1-9. doi: 10.1080/13506129.2019.1646639. [Epub ahead of print]

PMID:
31364411
2.

Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice.

Witteles RM, Bokhari S, Damy T, Elliott PM, Falk RH, Fine NM, Gospodinova M, Obici L, Rapezzi C, Garcia-Pavia P.

JACC Heart Fail. 2019 Aug;7(8):709-716. doi: 10.1016/j.jchf.2019.04.010. Epub 2019 Jul 10. Review.

3.

Extracorporeal membrane oxygenation support in acute circulatory failure: A plea for regulation and better organization.

Flécher E, Guihaire J, Pozzi M, Ouattara A, Baudry G, Berthelot E, Beauvais F, Radu C, Dorent R, Sebbag L, Galli E, Roubille F, Damy T, Verhoye JP, Leprince P, Obadia JF, Lebreton G.

Arch Cardiovasc Dis. 2019 Jun - Jul;112(6-7):441-449. doi: 10.1016/j.acvd.2019.04.008. Epub 2019 Jun 25.

PMID:
31253558
4.

Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use.

Kwun J, Matignon M, Manook M, Guendouz S, Audard V, Kheav D, Poullot E, Gautreau C, Ezekian B, Bodez D, Damy T, Faivre L, Menouch D, Yoon J, Park J, Belhadj K, Chen D, Bilewski AM, Yi JS, Collins B, Stegall M, Farris AB, Knechtle S, Grimbert P.

J Am Soc Nephrol. 2019 Jul;30(7):1206-1219. doi: 10.1681/ASN.2018121254. Epub 2019 Jun 21.

PMID:
31227636
5.

Causes and consequences of cardiac fibrosis in patients referred for surgical aortic valve replacement.

Galat A, Guellich A, Bodez D, Lipskaia L, Moutereau S, Bergoend E, Hüe S, Ternacle J, Mohty D, Monin JL, Derumeaux G, Radu C, Damy T.

ESC Heart Fail. 2019 Aug;6(4):649-657. doi: 10.1002/ehf2.12451. Epub 2019 May 21.

6.

Renal Infarction and Its Consequences for Renal Function in Patients With Cardiac Amyloidosis.

Dang J, Abulizi M, Moktefi A, El Karoui K, Deux JF, Bodez D, Le Bras F, Belhadj K, Remy P, Issaurat P, Plante-Bordeneuve V, Molinier-Frenkel V, Fanen P, Guendouz S, Kharoubi M, Itti E, Damy T, Audard V.

Mayo Clin Proc. 2019 Jun;94(6):961-975. doi: 10.1016/j.mayocp.2019.02.012. Epub 2019 May 15.

PMID:
31103217
7.

Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS).

Damy T, Kristen AV, Suhr OB, Maurer MS, Planté-Bordeneuve V, Yu CR, Ong ML, Coelho T, Rapezzi C; THAOS Investigators.

Eur Heart J. 2019 Apr 1. pii: ehz173. doi: 10.1093/eurheartj/ehz173. [Epub ahead of print]

PMID:
30938420
8.

Fabry disease in cardiology practice: Literature review and expert point of view.

Hagège A, Réant P, Habib G, Damy T, Barone-Rochette G, Soulat G, Donal E, Germain DP.

Arch Cardiovasc Dis. 2019 Apr;112(4):278-287. doi: 10.1016/j.acvd.2019.01.002. Epub 2019 Feb 28. Review.

PMID:
30826269
9.

Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations.

Conceição I, Damy T, Romero M, Galán L, Attarian S, Luigetti M, Sadeh M, Sarafov S, Tournev I, Ueda M.

Amyloid. 2019 Mar;26(1):3-9. doi: 10.1080/13506129.2018.1556156. Epub 2019 Feb 22.

PMID:
30793974
10.

Left ventricular assessment in patients with systemic light chain amyloidosis: a 3-dimensional speckle tracking transthoracic echocardiographic study.

Pradel S, Magne J, Jaccard A, Fadel BM, Boulogne C, Salemi VMC, Damy T, Aboyans V, Mohty D.

Int J Cardiovasc Imaging. 2019 May;35(5):845-854. doi: 10.1007/s10554-018-01524-2. Epub 2019 Jan 8.

PMID:
30623354
11.

Hospitalisation and life support in the year before and during heart transplantation: a French national study.

Cantrelle C, Dorent R, Legeai C, Damy T, Bastien O, Tuppin P.

Open Heart. 2018 Dec 9;5(2):e000913. doi: 10.1136/openhrt-2018-000913. eCollection 2018.

12.

Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis.

Solomon SD, Adams D, Kristen A, Grogan M, González-Duarte A, Maurer MS, Merlini G, Damy T, Slama MS, Brannagan TH 3rd, Dispenzieri A, Berk JL, Shah AM, Garg P, Vaishnaw A, Karsten V, Chen J, Gollob J, Vest J, Suhr O.

Circulation. 2019 Jan 22;139(4):431-443. doi: 10.1161/CIRCULATIONAHA.118.035831.

PMID:
30586695
13.

Targeted panel sequencing in adult patients with left ventricular non-compaction reveals a large genetic heterogeneity.

Richard P, Ader F, Roux M, Donal E, Eicher JC, Aoutil N, Huttin O, Selton-Suty C, Coisne D, Jondeau G, Damy T, Mansencal N, Casalta AC, Michel N, Haentjens J, Faivre L, Lavoute C, Nguyen K, Tregouët DA, Habib G, Charron P.

Clin Genet. 2019 Mar;95(3):356-367. doi: 10.1111/cge.13484. Epub 2018 Dec 27.

14.

Influence of centre expertise on the diagnosis and management of hypertrophic cardiomyopathy: A study from the French register of hypertrophic cardiomyopathy (REMY).

Mirabel M, Damy T, Donal E, Huttin O, Labombarda F, Eicher JC, Cervino C, Laurito M, Offredo L, Tafflet M, Jouven X, Giura G, Desnos M, Jeunemaître X, Empana JP, Charron P, Habib G, Réant P, Hagège A; REMY working group of the French Society of Cardiology.

Int J Cardiol. 2019 Jan 15;275:107-113. doi: 10.1016/j.ijcard.2018.09.083. Epub 2018 Sep 28.

PMID:
30316646
15.

Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice.

McDonagh T, Damy T, Doehner W, Lam CSP, Sindone A, van der Meer P, Cohen-Solal A, Kindermann I, Manito N, Pfister O, Pohjantähti-Maaroos H, Taylor J, Comin-Colet J.

Eur J Heart Fail. 2018 Dec;20(12):1664-1672. doi: 10.1002/ejhf.1305. Epub 2018 Oct 12. Review.

16.

Development and Validation of a New Tool to Assess Burden of Dietary Sodium Restriction in Patients with Chronic Heart Failure: The BIRD Questionnaire.

Audureau E, Guellich A, Guéry E, Canouï-Poitrine F, Benedyga V, Duchossoir H, Taieb C, Damy T.

Nutrients. 2018 Oct 7;10(10). pii: E1453. doi: 10.3390/nu10101453.

17.

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.

Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators.

N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27.

18.

Author's reply.

Mohty D, Petitalot V, Magne J, Fadel BM, Boulogne C, Rouabhia D, Hamel CE, Lavergne D, Damy T, Aboyans V, Jaccard A.

J Cardiol. 2018 Oct;72(4):368. doi: 10.1016/j.jjcc.2018.02.004. No abstract available.

PMID:
30122209
19.

Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis.

Ridouani F, Damy T, Tacher V, Derbel H, Legou F, Sifaoui I, Audureau E, Bodez D, Rahmouni A, Deux JF.

J Cardiovasc Magn Reson. 2018 Aug 16;20(1):58. doi: 10.1186/s12968-018-0478-3.

20.

Assessment of autonomic innervation of the foot in familial amyloid polyneuropathy.

Zouari HG, Ng Wing Tin S, Wahab A, Damy T, Lefaucheur JP.

Eur J Neurol. 2019 Jan;26(1):94-e10. doi: 10.1111/ene.13774. Epub 2018 Sep 12.

PMID:
30102818
21.

Quantification of Myocardial Enhancement on Cine-MRI: Diagnostic Value in Cardiac Amyloidosis.

Cholet C, Damy T, Legou F, Kobeiter H, Rahmouni A, Deux JF.

Acad Radiol. 2019 Jun;26(6):e98-e107. doi: 10.1016/j.acra.2018.06.021. Epub 2018 Jul 31.

PMID:
30072291
22.

Pulmonary hypertension in chronic heart failure: definitions, advances, and unanswered issues.

Berthelot E, Bauer F, Eicher JC, Flécher E, Gellen B, Guihaire J, Guijarro D, Roul G, Salvat M, Tribouilloy C, Zores F, Lamblin N, de Groote P, Damy T.

ESC Heart Fail. 2018 Oct;5(5):755-763. doi: 10.1002/ehf2.12316. Epub 2018 Jul 20. Review.

23.

The value of electrochemical skin conductance measurement using Sudoscan® in the assessment of patients with familial amyloid polyneuropathy.

Lefaucheur JP, Zouari HG, Gorram F, Nordine T, Damy T, Planté-Bordeneuve V.

Clin Neurophysiol. 2018 Aug;129(8):1565-1569. doi: 10.1016/j.clinph.2018.05.005. Epub 2018 May 29.

PMID:
29883834
24.

Outcome of patients with cardiac amyloidosis admitted to an intensive care unit for acute heart failure.

d'Humières T, Fard D, Damy T, Roubille F, Galat A, Doan HL, Oliver L, Dubois-Randé JL, Squara P, Lim P, Ternacle J.

Arch Cardiovasc Dis. 2018 Oct;111(10):582-590. doi: 10.1016/j.acvd.2018.03.004. Epub 2018 Apr 27.

PMID:
29709420
25.

Myocardial Stiffness Evaluation Using Noninvasive Shear Wave Imaging in Healthy and Hypertrophic Cardiomyopathic Adults.

Villemain O, Correia M, Mousseaux E, Baranger J, Zarka S, Podetti I, Soulat G, Damy T, Hagège A, Tanter M, Pernot M, Messas E.

JACC Cardiovasc Imaging. 2019 Jul;12(7 Pt 1):1135-1145. doi: 10.1016/j.jcmg.2018.02.002. Epub 2018 Mar 14.

26.

Left atrial function in patients with light chain amyloidosis: A transthoracic 3D speckle tracking imaging study.

Mohty D, Petitalot V, Magne J, Fadel BM, Boulogne C, Rouabhia D, ElHamel C, Lavergne D, Damy T, Aboyans V, Jaccard A.

J Cardiol. 2018 Apr;71(4):419-427. doi: 10.1016/j.jjcc.2017.10.007. Epub 2017 Nov 16.

27.

[Heart failure, progress and challenges].

Damy T.

Soins. 2017 Nov;62(820):20-21. doi: 10.1016/j.soin.2017.09.003. French.

28.

A new staging system for cardiac transthyretin amyloidosis.

Gillmore JD, Damy T, Fontana M, Hutchinson M, Lachmann HJ, Martinez-Naharro A, Quarta CC, Rezk T, Whelan CJ, Gonzalez-Lopez E, Lane T, Gilbertson JA, Rowczenio D, Petrie A, Hawkins PN.

Eur Heart J. 2018 Aug 7;39(30):2799-2806. doi: 10.1093/eurheartj/ehx589.

PMID:
29048471
29.

Myocardial iodine concentration measurement using dual-energy computed tomography for the diagnosis of cardiac amyloidosis: a pilot study.

Chevance V, Damy T, Tacher V, Legou F, Ridouani F, Luciani A, Kobeiter H, Rahmouni A, Deux JF.

Eur Radiol. 2018 Feb;28(2):816-823. doi: 10.1007/s00330-017-4984-8. Epub 2017 Aug 10.

PMID:
28812126
30.

How your ears can tell what is hidden in your heart: wild-type transthyretin amyloidosis as potential cause of sensorineural hearing loss inelderly-AmyloDEAFNESS pilot study.

Béquignon E, Guellich A, Barthier S, Raynal M, Prulière-Escabasse V, Canouï-Poitrine F, Coste A, Damy T.

Amyloid. 2017 Jun;24(2):96-100. doi: 10.1080/13506129.2017.1330744. Epub 2017 Jun 9.

PMID:
28598686
31.

Apical sparing pattern of left ventricular myocardial 99mTc-HMDP uptake in patients with transthyretin cardiac amyloidosis.

Van Der Gucht A, Cottereau AS, Abulizi M, Guellich A, Blanc-Durand P, Israel JM, Galat A, Plante-Bordeneuve V, Dubois-Randé JL, Bodez D, Rosso J, Damy T, Itti E.

J Nucl Cardiol. 2018 Dec;25(6):2072-2079. doi: 10.1007/s12350-017-0894-z. Epub 2017 Apr 26.

PMID:
28447284
32.

Refine penetrance estimates in the main pathogenic variants of transthyretin hereditary (familial) amyloid polyneuropathy (TTR-FAP) using a new non-parametric approach (NPSE).

Gorram F, Alarcon F, Perdry H, Hébrard B, Damy T, Fanen P, Funalot B, Nuel G, Planté-Bordeneuve V.

Amyloid. 2017 Mar;24(sup1):115-116. doi: 10.1080/13506129.2017.1293515. No abstract available.

PMID:
28434346
33.

Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS).

Kristen AV, Maurer MS, Rapezzi C, Mundayat R, Suhr OB, Damy T; THAOS investigators.

PLoS One. 2017 Apr 6;12(4):e0173086. doi: 10.1371/journal.pone.0173086. eCollection 2017.

34.

Exercise Training in a Patient With a Left Ventricular Assist Device and Large Aortic Valve Thrombus.

Wuliya M, Peyrot S, Radu C, Deux JF, Ben Elhaj H, Lellouche N, Damy T, Guendouz S, Gellen B.

J Cardiopulm Rehabil Prev. 2017 Nov;37(6):421-423. doi: 10.1097/HCR.0000000000000239.

PMID:
28350641
35.

Sequential cyclophosphamide-bortezomib-dexamethasone unmasks the harmful cardiac effect of dexamethasone in primary light-chain cardiac amyloidosis.

Le Bras F, Molinier-Frenkel V, Guellich A, Dupuis J, Belhadj K, Guendouz S, Ayad K, Colombat M, Benhaiem N, Tissot CM, Hulin A, Jaccard A, Damy T.

Eur J Cancer. 2017 May;76:183-187. doi: 10.1016/j.ejca.2017.02.004. Epub 2017 Mar 20.

PMID:
28334621
36.

Isolated Pericardial Infiltration Without Myocardial Involvement in Light-Chain-Related Amyloidosis.

Georgin-Lavialle S, Guellich A, Deux JF, Buob D, Damy T.

Ann Thorac Surg. 2017 Mar;103(3):e255-e257. doi: 10.1016/j.athoracsur.2016.08.108.

PMID:
28219562
37.

Impact of Pulmonary Hypertension on Outcome in Patients with Severe Aortic Stenosis and Preserved Left Ventricular Ejection Fraction.

Magne J, Mohty D, Piccardo A, Boulogne C, Deltreuil M, Petitalot V, Echahidi N, Darodes N, Virot P, Damy T, Aboyans V.

Clin Res Cardiol. 2017 Jul;106(7):542-550. doi: 10.1007/s00392-017-1085-2. Epub 2017 Feb 14.

PMID:
28194496
38.

New guidelines, new recommendations! But what is really new? A pragmatic interpretation of the 2016 European guidelines for the management of chronic heart failure.

de Groote P, Cohen A, Juillière Y, Damy T.

Arch Cardiovasc Dis. 2017 Jan;110(1):1-6. doi: 10.1016/j.acvd.2016.12.001. Epub 2017 Jan 9. No abstract available.

39.

Patient journey in decompensated heart failure: An analysis in departments of cardiology and geriatrics in the Greater Paris University Hospitals.

Laveau F, Hammoudi N, Berthelot E, Belmin J, Assayag P, Cohen A, Damy T, Duboc D, Dubourg O, Hagege A, Hanon O, Isnard R, Jondeau G, Labouree F, Logeart D, Mansencal N, Meune C, Pautas E, Wolmark Y, Komajda M.

Arch Cardiovasc Dis. 2017 Jan;110(1):42-50. doi: 10.1016/j.acvd.2016.05.009. Epub 2016 Dec 21.

40.

Prevalence and prognostic impact of left-sided valve thickening in systemic light-chain amyloidosis.

Mohty D, Pradel S, Magne J, Fadel B, Boulogne C, Petitalot V, Raboukhi S, Darodes N, Damy T, Aboyans V, Jaccard A.

Clin Res Cardiol. 2017 May;106(5):331-340. doi: 10.1007/s00392-016-1058-x. Epub 2016 Dec 8.

PMID:
27933393
41.

Myocardial Gene Expression Profiling to Predict and Identify Cardiac Allograft Acute Cellular Rejection: The GET-Study.

Bodez D, Hocini H, Tchitchek N, Tisserand P, Benhaiem N, Barau C, Kharoubi M, Guellich A, Guendouz S, Radu C, Couetil JP, Ghaleh B, Dubois-Randé JL, Teiger E, Hittinger L, Levy Y, Damy T.

PLoS One. 2016 Nov 29;11(11):e0167213. doi: 10.1371/journal.pone.0167213. eCollection 2016.

42.

Long-term treatment of transthyretin familial amyloid polyneuropathy with tafamidis: a clinical and neurophysiological study.

Planté-Bordeneuve V, Gorram F, Salhi H, Nordine T, Ayache SS, Le Corvoisier P, Azoulay D, Feray C, Damy T, Lefaucheur JP.

J Neurol. 2017 Feb;264(2):268-276. doi: 10.1007/s00415-016-8337-3. Epub 2016 Nov 22.

PMID:
27878441
43.

Non-vitamin K antagonist oral anticoagulants and heart failure.

Isnard R, Bauer F, Cohen-Solal A, Damy T, Donal E, Galinier M, Hagège A, Jourdain P, Leclercq C, Sabatier R, Trochu JN, Cohen A.

Arch Cardiovasc Dis. 2016 Nov;109(11):641-650. doi: 10.1016/j.acvd.2016.08.001. Epub 2016 Nov 8. Review.

44.

Arterio-venous fistula for automated red blood cells exchange in patients with sickle cell disease: Complications and outcomes.

Delville M, Manceau S, Ait Abdallah N, Stolba J, Awad S, Damy T, Gellen B, Sabbah L, Debbache K, Audard V, Beaumont JL, Arnaud C, Chantalat-Auger C, Driss F, Lefrère F, Cavazzana M, Franco G, Galacteros F, Ribeil JA, Gellen-Dautremer J.

Am J Hematol. 2017 Feb;92(2):136-140. doi: 10.1002/ajh.24600. Epub 2016 Dec 7.

45.

Early-phase myocardial uptake intensity of 99mTc-HMDP vs 99mTc-DPD in patients with hereditary transthyretin-related cardiac amyloidosis.

Abulizi M, Cottereau AS, Guellich A, Vandeventer S, Galat A, Van Der Gucht A, Plante-Bordeneuve V, Dubois-Randé JL, Bodez D, Rosso J, Damy T, Itti E.

J Nucl Cardiol. 2018 Feb;25(1):217-222. doi: 10.1007/s12350-016-0707-9. Epub 2016 Nov 1.

PMID:
27804073
46.

[Cardiac amyloidosis: How to recognize them and manage them?]

Bodez D, Galat A, Guellich A, Deux JF, Rosso J, Le Bras F, Funalot B, Fanen P, Benhaiem N, Planté-Bordeneuve V, Dubois-Randé JL, Lellouche N, Guendouz S, Molinier-Frenkel V, Mohty D, Damy T.

Presse Med. 2016 Oct;45(10):845-855. doi: 10.1016/j.lpm.2016.07.001. Epub 2016 Aug 1. French.

PMID:
27492996
47.

Identification of prognostic markers in transthyretin and AL cardiac amyloidosis.

Damy T, Jaccard A, Guellich A, Lavergne D, Galat A, Deux JF, Hittinger L, Dupuis J, Frenkel V, Rigaud C, Plante-Bordeneuve V, Bodez D, Mohty D.

Amyloid. 2016 Sep;23(3):194-202. Epub 2016 Sep 20.

PMID:
27647161
48.

Prognostic value of right ventricular systolic function in cardiac amyloidosis.

Bodez D, Ternacle J, Guellich A, Galat A, Lim P, Radu C, Guendouz S, Bergoend E, Couetil JP, Hittinger L, Dubois-Randé JL, Plante-Bordeneuve V, Deux JF, Mohty D, Damy T.

Amyloid. 2016 Sep;23(3):158-167. Epub 2016 Jun 27.

PMID:
27348696
49.

Usefulness of T2 ratio in the diagnosis and prognosis of cardiac amyloidosis using cardiac MR imaging.

Legou F, Tacher V, Damy T, Planté-Bordeneuve V, Rappeneau S, Benhaiem N, Rosso J, Itti E, Luciani A, Kobeiter H, Rahmouni A, Deux JF.

Diagn Interv Imaging. 2017 Feb;98(2):125-132. doi: 10.1016/j.diii.2016.08.007. Epub 2016 Sep 28.

50.

Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis.

Hamon D, Algalarrondo V, Gandjbakhch E, Extramiana F, Marijon E, Elbaz N, Selhane D, Dubois-Rande JL, Teiger E, Plante-Bordeneuve V, Damy T, Lellouche N.

Int J Cardiol. 2016 Nov 1;222:562-568. doi: 10.1016/j.ijcard.2016.07.254. Epub 2016 Aug 1.

PMID:
27513652

Supplemental Content

Support Center